Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BMS seeks $1 billion balance sheet boost

This article was originally published in Scrip

Executive Summary

Bristol-Myers Squibbplans to strengthen its balance sheet with up to an additional $1 billion by 2011 from improvements in working capital. Chief financial officer Jean-Marc Huet said that the company would increase the speed of payments made to BMS from partners and vendors and would slow down payments going out from the firm. BMS also wants to improve commercial terms and the accuracy of its inventory audits. Currently, the company has around $7.2 billion in cash and expects to receive an additional $1 billion from the sale of its 16.6% stake in ImClone SystemstoLilly.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts